UM Calabresi Clinical Oncology Research Career Development Award

项目总结 迈阿密大学卡拉布雷西临床肿瘤学研究职业发展计划 启动致力于以患者为中心的癌症研究的临床研究人员的职业生涯。 识别这些人并促进他们的职业发展将确保新一代 临床医生学者可以有效地将科学发现转化为临床研究机会，从而改善 提供癌症护理，并相应地提供患者结果。截至最近，迈阿密大学西尔维斯特大学 综合性癌症中心在基础、转换和人口方面都经历了大幅增长 科学计划，并拥有必要的基础设施，以支持成功的K12计划。这个有一个 优秀的翻译和临床导师队伍，以及一大批强大和引人注目的 不同潜力的K12学者推出拟议的职业发展计划。 那些 辐射， 教职员工 和 大学的 实习 这样的 的 学者们将包括 世卫组织最近完成了一个肿瘤学专科项目的研究生培训(儿科、泌尿科、 外科、血液学、头颈部、妇科)和最近首次 预约。学者们将选择由翻译导师和临床导师组成的导师二人组， 将有权获得临床和翻译研究硕士学位，由我们的 临床翻译科学研究所。学者将从广泛的课程中进行选择，并 旨在帮助他们将研究发现转化为临床实践。然后他们将使用 设计、实施和管理临床癌症治疗试验的知识，从研究结果中得出结论 由K12导师领导的持续的翻译和基于人口的研究计划。UM K12计划 将实现卡拉布雷西奖的主要目标。它将在两年期间提供专门的时间， 在开发以患者为中心的新型临床试验方面的最佳指导、正规教育和实践经验 给一群才华横溢、积极进取的临床学者。该计划将评估短期和 学者职业轨迹的长期结果，并使用相应的数据来调整方案以 适当地满足动态和快速变化的临床肿瘤学研究的格局。一个重要的 UM K12计划的特点是其位于佛罗里达州南部的地理位置，其特点是 无与伦比的多元文化。这种多样性提供了一个独特的机会来开发对 种族/少数民族、新移民和其他人口亚群的独特需求，他们为 癌症差异。

PROJECT SUMMARY The University of Miami (UM) Calabresi Clinical Oncology Research Career Development program is designed to launch the careers of clinical researchers committed to pursuing patient-oriented cancer research. Identifying such individuals and facilitating their career development will ensure that a new generation of clinician scholars can effectively translate scientific discovery to clinical research opportunities that improve the delivery of cancer care and accordingly, patient outcomes. As of recent, the University of Miami Sylvester Comprehensive Cancer Center has experienced substantial growth in its basic, translational and population science programs and has necessary infrastructure to support a successful K12 Program. UM has an outstanding cadre of Translational and Clinical Mentors, as well as, a large pool of strong and remarkably diverse potential K12 scholars to launch the proposed career development program. those radiation, faculty and University's practicums such of Scholars will include who recently completed postgraduate training in a subspecialty oncology program (pediatric, urologic, surgical, hematology, head and neck, gynecologic) and those who have recently assumed their first appointment. Scholars will choose a mentoring dyad composed of a Translational and a Clinical Mentor, will have the option of obtaining a Masters in Clinical and Translational Investigation, supported by our Clinical Translational Science Institute. Scholars will choose from a wide range of courses and designed to assist them in translating research discoveries into clinical practice. They will then use knowledge to design, implement and manage a clinical cancer therapy trial , which draws from the findings ongoing translational and population-based research initiatives led by K12 mentors.The UM K12 Program will fulfill the major objectives of the Calabresi Award. It will provide, for a two-year period, dedicated time, optimal mentorship, formal education, and practical experience in developing novel, patient centric clinical trials to a diverse group of talented, and highly-motivated clinical Scholars. The Program will evaluate short and long-term outcomes of scholars' professional trajectory and use corresponding data to adjust the program to appropriately meet the dynamic and rapidly changing landscape of clinical oncology research. An important feature of the UM K12 Program is its geographic location in South Florida, which is characterized by unparalleled multiculturalism. Such diversity provides a unique opportunity to develop trials responsive to the unique needs of racial/ethnic minorities, recent immigrants, and other population sub-groups, who contribute to cancer disparity.